Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only-Reference-Cited by-同舟云学术

Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only

Published:2020-10-22 Issue:12 Volume:34 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

LeBlanc Richard¹^ORCID,Claveau Jean‐Sébastien¹,Ahmad Imran¹,Delisle Jean‐Sébastien¹,Bambace Nadia¹,Bernard Léa¹,Cohen Sandra¹,Kiss Thomas¹,Lachance Silvy¹,Landais Séverine¹,Roy Denis Claude¹,Sauvageau Guy¹,Roy Jean¹

Affiliation:

1. Division of Hematology, Oncology and Transplantation Hôpital Maisonneuve‐Rosemont and Université de Montréal Montréal QC Canada

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14099

Reference29 articles.

1. Role of stem cell transplant and maintenance therapy in plasma cell disorders

2. Long-term outcomes after autologous stem cell transplantation for multiple myeloma

3. Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation